Filing Details

Accession Number:
0001140361-12-051331
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-12-14 17:39:16
Reporting Period:
2012-12-12
Filing Date:
2012-12-14
Accepted Time:
2012-12-14 17:39:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
3116 Akorn Inc AKRX Pharmaceutical Preparations (2834) 720717400
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1124179 J Steven Meyer 1925 West Field Court Suite 300
Lake Forest IL 60045
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-12-12 10,000 $0.94 66,500 No 4 M Direct
Common Stock Disposition 2012-12-12 701 $13.45 65,799 No 4 S Direct
Common Stock Acquisiton 2012-12-12 10,000 $0.94 75,799 No 4 M Direct
Common Stock Disposition 2012-12-12 10,000 $13.72 65,799 No 4 S Direct
Common Stock Acquisiton 2012-12-12 10,000 $2.61 75,799 No 4 M Direct
Common Stock Disposition 2012-12-12 10,000 $13.42 65,799 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2012-12-12 20,000 $0.00 20,000 $0.94
Common Stock Stock Option (Right to Buy) Acquisiton 2012-12-12 10,000 $0.00 10,000 $2.61
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
50,000 2009-06-22 2014-06-22 No 4 M Direct
40,000 2010-05-21 2015-05-21 No 4 M Direct
Footnotes
  1. Options fully vested and became exercisable immediately upon grant.
  2. There was no consideration given in exchange for the security.